EP 208: Gene therapy at a crossroads: Successes, concerns, and the path forward
Автор: Sano Genetics
Загружено: 2025-10-09
Просмотров: 79
Описание:
This week on The Genetics Podcast, Patrick Short takes a solo deep dive into the current state of gene therapy ahead of next week’s live recording at ASHG 2025. He explores the promise and limitations of adeno-associated virus (AAV) delivery, examples of gene therapies for neuromuscular diseases, and the challenges of balancing safety, cost, and commercial viability in rare diseases.
Show Notes:
0:00 Intro to The Genetics Podcast
00:59 Episode overview
02:50 Definition and scope of gene therapy
04:50 Gene therapy delivery via adeno-associated virus (AAV) and associated challenges and advantages
06:40 AAV-based gene therapy and other advanced therapies in spinal muscular atrophy (SMA)
10:29 Recent safety concerns around Sarepta Therapeutics’ AAV-based gene therapy for Duchenne muscular dystrophy (DMD)
19:30 Commercial viability challenges for rare disease gene therapy
24:26 Risk-benefit analysis of gene therapy for rare diseases
28:33 Considerations for optimizing AAV design and delivery routes
31:26 Alternative approaches for delivery using viral and non-viral methods
36:09 The future of AAV gene therapy
41:42 Closing remarks
Find out more
Update on Sarepta Therapeutics’ gene therapy for DMD (https://www.fiercepharma.com/pharma/s...)
#TheGeneticsPodcast #Genetics #PrecisionMedicine #GeneTherapy #RareDisease #AAV
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Биология поведения человека. Лекция #1. Введение [Роберт Сапольски, 2010. Стэнфорд]](https://ricktube.ru/thumbnail/ik9t96SMtB0/mqdefault.jpg)
